| Tue, Jun 16, 2009 | | | Biotech Calendar: More Key Clinical Trial Dates at TheStreet.com (Tue, Jun 16)
| | Wed, Jun 10, 2009 | | | Vivus' Qnexa Impresses at ADA Zacks.com (Wed, Jun 10)
| | | NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials at Seeking Alpha (Wed, Jun 10)
| | Tue, Jun 9, 2009 | | | VIVUS says obesity drug aided blood sugar control AP (Tue, Jun 9)
| | Mon, Jun 8, 2009 | | | VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes PR Newswire (Mon, Jun 8)
| | Sat, Jun 6, 2009 | | | Weight Loss With Qnexa Stops Progression Toward Type 2 Diabetes in Obese Non-Diabetic Patients PR Newswire (Sat, Jun 6)
| | Wed, Jun 3, 2009 | | | VIVUS to Present at the Needham and Company Life Sciences Conference PR Newswire (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | | Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting PR Newswire (Tue, Jun 2)
| | Wed, May 20, 2009 | | | VIVUS INC Financials EDGAR Online Financials (Wed, May 20)
| | Tue, May 19, 2009 | | | 5 Stocks Approaching Greatness at Motley Fool (Tue, May 19)
| | Wed, May 13, 2009 | | | VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction PR Newswire (Wed, May 13)
| | Tue, May 12, 2009 | | | Vivus' Qnexa in the Driver's Seat Zacks.com (Tue, May 12)
| | | Earnings roundup: Fossil, Vivus AP (Tue, May 12)
| | | The Skinny on ARNA's Lorcaserin Zacks.com (Tue, May 12)
| | | New Star Analyst Rankings for VIVUS, Inc. StarMine (Tue, May 12)
| | | Vivus 1Q loss narrows on lower development costs AP (Tue, May 12)
| | | Vivus: Still Undervalued at Seeking Alpha (Tue, May 12)
| | Mon, May 11, 2009 | | | VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online (Mon, May 11)
| | | VIVUS Reports First Quarter 2009 Financial Results and Highlights PR Newswire (Mon, May 11)
| | | Q1 2009 Vivus, Inc. Earnings Release - After Market Close CCBN (Mon, May 11)
| Add VVUS News to My Yahoo!:

| |
|